Home
Brain tumour immunology and therapy group

News archive for Brain tumour immunology and therapy group

Our new paper "Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival" has been published in British Journal of Cancer.